0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Prescribing Behavior
 41-60 of 128 Articles
Editorial | 
Jonathan A. Finkelstein, MD, MPH
JAMA. 2013;309(22):2388-2389. doi:10.1001/jama.2013.6288.

Viewpoint | 
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA. 2013;309(21):2219-2220. doi:10.1001/jama.2013.5794.

Medical News and Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;309(15):1573-1574. doi:10.1001/jama.2013.2922.

JAMA Patient Page |  FREE
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(13):1419. doi:10.1001/jama.2013.3041.
Includes: Supplemental Content

Care of the Aging Patient: From Evidence to Action | 
Meredith Greene, MD; Amy C. Justice, MD, PhD; Harry W. Lampiris, MD; et al.
JAMA. 2013;309(13):1397-1405. doi:10.1001/jama.2013.2963.
Includes: Supplemental Content

Clinical Crossroads | 
Daniel P. Alford, MD, MPH
JAMA. 2013;309(9):919-925. doi:10.1001/jama.2013.522.
Includes: CME

Viewpoint | 
David N. Juurlink, MD, PhD; Irfan A. Dhalla, MD, MSc; Lewis S. Nelson, MD
JAMA. 2013;309(9):879-880. doi:10.1001/jama.2013.1139.

Research Letters |  FREE
Christopher M. Jones, PharmD; Karin A. Mack, PhD; Leonard J. Paulozzi, MD
JAMA. 2013;309(7):657-659. doi:10.1001/jama.2013.272.

JAMA Clinical Evidence Synopsis | 
Philipp Schuetz, MD, MPH; Matthias Briel, MD, MSc; Beat Mueller, MD
JAMA. 2013;309(7):717-718. doi:10.1001/jama.2013.697.

From the Centers for Disease Control and Prevention | 
JAMA. 2013;309(6):536-538. doi:10.1001/jama.2012.217206.

Viewpoint | 
Aaron S. Kesselheim, MD, JD, MPH; Michelle M. Mello, JD, PhD, MPhil; Jerry Avorn, MD
JAMA. 2013;309(5):445-446. doi:10.1001/jama.2012.207972.

Research Letters |  FREE
Azalea Kim, MPA; Lawrence A. Mumm, BA; Deborah Korenstein, MD
JAMA. 2012;308(21):2187-2189. doi:10.1001/jama.2012.25315.

Viewpoint | 
G. Caleb Alexander, MD, MS; Stefan P. Kruszewski, MD; Daniel W. Webster, ScD, MPH
JAMA. 2012;308(18):1865-1866. doi:10.1001/jama.2012.14282.

Viewpoint | 
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;308(13):1307. doi:10.1001/jama.2012.13019.

Research Letters |  FREE
Jeremy A. Greene, MD, PhD; Niteesh K. Choudhry, MD, PhD; Aaron S. Kesselheim, MD, JD, MPH; et al.
JAMA. 2012;308(10):973-975. doi:10.1001/2012.jama.10647.

Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.

Viewpoint | 
Lewis S. Nelson, MD; Jeanmarie Perrone, MD
JAMA. 2012;308(5):457-458. doi:10.1001/jama.2012.8165.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;307(9):894-895. doi:10.1001/jama.2012.217.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2011;306(22):2452. doi:.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Viewpoint  | 
Proposed US Food and Drug Administration Guidance for Industry on Distributing Medical Publications About the Risks of Prescription Drugs and Biological Products:  A Misguided Approach
Sidney M. Wolfe, MD
JAMA Internal Medicine
Editor's Note  | 
Restricting Interactions With Industry to Promote Evidence-Based Prescribing
Joseph S. Ross, MD, MHS
JAMA Internal Medicine
Original Investigation  | 
Association of Marketing Interactions With Medical Trainees’ Knowledge About Evidence-Based Prescribing:  Results From a National Survey
Kirsten E. Austad, MD; Jerry Avorn, MD; Jessica M. Franklin, PhD; et al.
JAMA Internal Medicine
Perspective  | 
Balancing the Benefits and Risks of Empirical Antibiotics for Sinusitis:  A Teachable Moment
Avery MacKenzie, MD